MP
ADPT icon

McDonald Partners’s Adaptive Biotechnologies ADPT Stock Holding History

McDonald Partners’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-50,694
Closed -$704K – 297
2022
Q1 		$704K Buy
+50,694
New +$797K 0.15% 165
2021
Q4 		– Sell
-50,694
Closed -$1.72M – 551
2021
Q3 		$1.72M Buy
50,694
+11
+0% +$398 0.4% 70
2021
Q2 		$2.07M Hold
50,683
– – 0.49% 55
2021
Q1 		$2.04M Sell
50,683
-5,031
-9% -$272K 0.52% 53
2020
Q4 		$3.29M Buy
+55,714
New +$2.87M 0.93% 23

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
BWLSA
Blue Water Life Science Advisors Larkspur, California $159M AUM 139.66% 1-Year Est. Return

McDonald Partners's ADPT Position: Q2 2022 in Review

McDonald Partners sold out of Adaptive Biotechnologies (ADPT) in Q2 2022, closing a stake of 50,694 shares — an estimated $704K sold.

McDonald Partners first reported a position in ADPT in Q4 2020 and held it in 5 quarters. The position peaked at $3.29M in Q4 2020. 209 funds tracked by Wall St. Rank hold ADPT as of Q2 2022.

  • McDonald Partners reported no remaining Adaptive Biotechnologies position as of Q2 2022 after selling out during the quarter.
  • McDonald Partners sold 50,694 Adaptive Biotechnologies shares in Q2 2022, an estimated $704K.
  • McDonald Partners first reported a position in Adaptive Biotechnologies in Q4 2020 and held it in 5 quarters.
  • McDonald Partners's Adaptive Biotechnologies position peaked at $3.29M in Q4 2020.
  • 209 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2022.

Based on McDonald Partners's 13F filing for Q2 2022, filed 25 Jul 2022.